Ascend Wellness (OTC:AAWH) Lowered to “Strong Sell” Rating by Zacks Research

Zacks Research lowered shares of Ascend Wellness (OTC:AAWH) from a hold rating to a strong sell rating in a research report sent to investors on Tuesday,Zacks.com reports.

Ascend Wellness Trading Up 1.3%

AAWH opened at $0.62 on Tuesday. Ascend Wellness has a one year low of $0.26 and a one year high of $1.20. The company has a debt-to-equity ratio of 2.61, a current ratio of 1.47 and a quick ratio of 0.80. The business has a 50 day simple moving average of $0.67 and a two-hundred day simple moving average of $0.66. The firm has a market capitalization of $126.28 million, a price-to-earnings ratio of -1.51 and a beta of 1.11.

About Ascend Wellness

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores.